Page 1

INTERIM REPORT JANUARY - SEPTEMBER 2021 Vitrolife AB ( publ ) Vitrolife is an international medical device Group . Vitrolife develops , produces and markets products for assisted reproduction . Vitrolife has approximately 400 employees and the company's products are sold in approximately 110 markets . The company is headquartered in Gothenburg , Sweden , and there are also offices in Australia , Belgium , China , Denmark , France , Germany , Italy , Japan , United Kingdom and USA . The Vitrolife share is listed on NASDAQ Stockholm . Vitrolife